Ophthalmic Complications Associated With Sema...

Interview with Rupesh Agrawal, MMed, MD, and James T. Rosenbaum, MD, authors of Standardization of Retinal Vasculitis Terminology With Consensus Definitions From a Delphi Panel. Hosted by Neil Bressler, MD. Related Content: Standardization of Retinal Vasculitis Terminology With C ...  Show more

Interview with Iqbal Ike K. Ahmed, MD, and Jawad Muayad, MD, authors of Nicotinamide Supplementation and Primary Open-Angle Glaucoma in Patients With Ocular Hypertension. Hosted by Neil Bressler, MD. Related Content: Nicotinamide Supplementation and Primary Open-Angle Glaucoma in ...  Show more

Dr. Peter Quiros joins host Dr. Amanda Redfern to discuss the recent JAMA Ophthalmology article "The Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide," the first study to report a possible association between semaglutide (Wegovy, Ozempic, ...  Show more

Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema ...  Show more

New medications for obesity, such as semaglutide and tirzepatide, are highly effective but can be associated with adverse effects that reduce adherence. Obesity expert and author Robert Kushner, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss a recent JAMA Insights ar ...  Show more

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.